Urocortin2 measurement for heart failure assessment

被引:0
|
作者
Kohei Inukai [1 ]
Kazuya Miyashita [2 ]
Kazuhiko Kotani [3 ]
Ryota Morimoto [1 ]
Toru Kondo [1 ]
Hiroaki Hiraiwa [1 ]
Shingo Kazama [1 ]
Tatsuya Yoshida [1 ]
Satoya Yoshida [1 ]
Tomoki Hattori [1 ]
Kumiko Fukamachi [2 ]
Naoya Fukui [2 ]
Katsuhiro Kato [1 ]
Yoshimitsu Yura [1 ]
Koji Ohashi [4 ]
Noriyuki Ouchi [4 ]
Toyoaki Murohara [1 ]
Takahiro Okumura [1 ]
Mikito Takefuji [1 ]
机构
[1] Nagoya University Graduate School of Medicine,Department of Cardiology
[2] Immuno-Biological Laboratories,Division of Community and Family Medicine
[3] Jichi Medical University,Department of Molecular Medicine and Cardiology
[4] Nagoya University School of Medicine,undefined
关键词
Heart failure; UCN2; ELISA assay; CRHR2; GPCR; Peptide;
D O I
10.1038/s41598-025-99509-4
中图分类号
学科分类号
摘要
Despite the efficacy of many therapies for heart failure, it remains a leading cause of morbidity and mortality worldwide, with many patients progressing to advanced stages of the condition. Since the standard treatment for heart failure includes small-molecule drugs targeting G protein-coupled receptors (GPCRs), GPCRs are still considered novel targets for the diagnosis and treatment of cardiovascular diseases. Corticotropin-releasing hormone receptor 2, a highly expressed GPCR in cardiomyocytes, and its ligand, urocortin2 (UCN2), have been reportedly associated with cardiovascular diseases; however, their clinical significance remains unclear. In this study, a UCN2 measurement assay was developed to measure blood UCN2 levels in patients with heart failure. The assay showed that blood UCN2 values indicated a negative relationship with cardiac ejection fraction in 52 patients with heart failure. Blood UCN2 levels were not correlated with brain natriuretic peptide, a standard marker of heart failure, and were higher in patients with cardiomyopathy than in those with heart failure, suggesting that measuring blood UCN2 levels may be a novel test for assessing the pathophysiology of heart failure.
引用
收藏
相关论文
共 50 条
  • [1] Urocortin 2 infusion in human heart failure
    Davis, Mark E.
    Pemberton, Christopher J.
    Yandle, Timothy G.
    Fisher, Steve F.
    Lainchbury, John G.
    Frampton, Christopher M.
    Rademaker, Miriam T.
    Richards, Mark
    EUROPEAN HEART JOURNAL, 2007, 28 (21) : 2589 - 2597
  • [2] The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2
    Chen, Si
    Wang, Zhenhua
    Xu, Bo
    Mi, Xiangquan
    Sun, Wanqing
    Quan, Nanhu
    Wang, Lin
    Chen, Xingchi
    Liu, Quan
    Zheng, Yang
    Leng, Jiyan
    Li, Ji
    TOXICOLOGICAL SCIENCES, 2015, 148 (02) : 581 - 593
  • [3] UROCORTIN2 LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION TREATED WITH ACEI OR ARB
    Walczewska, J.
    Siga, O.
    Dzieza-Grudnik, A.
    Wolkow, P.
    Borys, A.
    Krolczyk, J.
    Wizner, B.
    Gryglewska, B.
    Grodzicki, T.
    JOURNAL OF HYPERTENSION, 2017, 35 : E65 - E65
  • [4] Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure
    Stirrat, Colin G.
    Venkatasubramanian, Sowmya
    Pawade, Tania
    Mitchell, Andrew J.
    Shah, Anoop S.
    Lang, Ninian N.
    Newby, David E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (04) : 974 - 982
  • [5] Cardiovascular effects of Urocortin 2 and Urocortin 3 in patients with heart failure and healthy volunteers
    Stirrat, Colin G.
    Ventakasubramanian, Sowmya
    Pawade, Tania
    Mitchell, Andrew J.
    Shah, Anoop
    Lang, Ninian N.
    Newby, David E.
    SCOTTISH MEDICAL JOURNAL, 2016, 61 (04) : NP45 - NP47
  • [6] Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation
    Hao, Zhengrong
    Huang, Yan
    Cleman, Jake
    Jovin, Ion S.
    Vale, Wylie W.
    Bale, Tracy L.
    Giordano, Frank J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) : 3939 - 3944
  • [7] Prostaglandins and NO Mediate the Urocortin2/ CRF2 Induced Relaxation of the Iris Sphincter Muscle
    Rocha-Sousa, A. A.
    Tavares-Silva, M.
    Fonseca, S.
    Cardoso, S.
    Azevedo-Pinto, S.
    Leite-Moreira, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [8] Further evidence to support a role for urocortin 2 in heart failure
    Moxon, Joseph V.
    Emeto, Theophilus I.
    Golledge, Jonathan
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (02): : 121 - 122
  • [9] Urocortin-2 Infusion in Acute Decompensated Heart Failure
    Chan, W. Y. Wandy
    Frampton, Christopher M.
    Crozier, Ian G.
    Troughton, Richard W.
    Richards, A. Mark
    JACC-HEART FAILURE, 2013, 1 (05) : 433 - 441
  • [10] Urocortin2 attenuates diabetic coronary microvascular dysfunction by regulating macrophage extracellular vesicles
    Zhu, Chao
    Zhou, Feier
    Mao, Rongchen
    Hong, Yali
    Wan, Rong
    Li, Xu
    Jin, Lai
    Zou, Huayiyang
    Zhang, Hao
    Chen, Qin M.
    Li, Shengnan
    BIOCHEMICAL PHARMACOLOGY, 2024, 219